vs
CF BANKSHARES INC.（CFBK）与Foghorn Therapeutics Inc.（FHTX）财务数据对比。点击上方公司名可切换其他公司
CF BANKSHARES INC.的季度营收约是Foghorn Therapeutics Inc.的1.7倍（$15.7M vs $9.2M），CF BANKSHARES INC.净利率更高（40.0% vs -234.3%，领先274.3%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs 12.6%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs 13.7%）
CF BANKSHARES INC.是一家美国区域性银行控股企业，通过旗下社区银行子公司运营，提供全方位个人及商业银行解决方案，包括存款产品、各类贷款、财富管理服务及数字银行工具，主要服务美国中西部地区的个人消费者和中小企客户。
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
CFBK vs FHTX — 直观对比
营收规模更大
CFBK
是对方的1.7倍
$9.2M
营收增速更快
FHTX
高出211.1%
12.6%
净利率更高
CFBK
高出274.3%
-234.3%
两年增速更快
FHTX
近两年复合增速
13.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $15.7M | $9.2M |
| 净利润 | $5.7M | $-21.7M |
| 毛利率 | — | — |
| 营业利润率 | 43.4% | -258.2% |
| 净利率 | 40.0% | -234.3% |
| 营收同比 | 12.6% | 223.8% |
| 净利润同比 | 29.9% | -11.1% |
| 每股收益（稀释后） | $0.88 | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CFBKFHTX
| Q4 25 | $15.7M | $9.2M | ||
| Q3 25 | $15.5M | $8.2M | ||
| Q2 25 | $15.6M | $7.6M | ||
| Q1 25 | $14.1M | $6.0M | ||
| Q4 24 | $14.0M | $2.9M | ||
| Q3 24 | $13.1M | $7.8M | ||
| Q2 24 | $12.6M | $6.9M | ||
| Q1 24 | $12.2M | $5.0M |
净利润CFBKFHTX
| Q4 25 | $5.7M | $-21.7M | ||
| Q3 25 | $2.3M | $-15.8M | ||
| Q2 25 | $5.0M | $-17.9M | ||
| Q1 25 | $4.4M | $-18.8M | ||
| Q4 24 | $4.4M | $-19.5M | ||
| Q3 24 | $4.2M | $-19.1M | ||
| Q2 24 | $1.7M | $-23.0M | ||
| Q1 24 | $3.1M | $-25.0M |
营业利润率CFBKFHTX
| Q4 25 | 43.4% | -258.2% | ||
| Q3 25 | 17.5% | -226.9% | ||
| Q2 25 | 41.1% | -279.2% | ||
| Q1 25 | 39.5% | -385.0% | ||
| Q4 24 | 36.9% | -840.5% | ||
| Q3 24 | 40.4% | -305.5% | ||
| Q2 24 | 15.4% | -386.6% | ||
| Q1 24 | 30.9% | -558.3% |
净利率CFBKFHTX
| Q4 25 | 40.0% | -234.3% | ||
| Q3 25 | 15.1% | -194.4% | ||
| Q2 25 | 32.3% | -237.3% | ||
| Q1 25 | 31.4% | -316.4% | ||
| Q4 24 | 35.2% | -682.9% | ||
| Q3 24 | 32.2% | -244.9% | ||
| Q2 24 | 13.5% | -333.6% | ||
| Q1 24 | 25.2% | -495.4% |
每股收益（稀释后）CFBKFHTX
| Q4 25 | $0.88 | $-0.35 | ||
| Q3 25 | $0.36 | $-0.25 | ||
| Q2 25 | $0.77 | $-0.28 | ||
| Q1 25 | $0.68 | $-0.30 | ||
| Q4 24 | $0.68 | $-0.23 | ||
| Q3 24 | $0.65 | $-0.31 | ||
| Q2 24 | $0.26 | $-0.45 | ||
| Q1 24 | $0.47 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $259.0M | $80.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $184.4M | $-108.5M |
| 总资产 | $2.1B | $198.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CFBKFHTX
| Q4 25 | $259.0M | $80.9M | ||
| Q3 25 | $272.4M | $89.3M | ||
| Q2 25 | $275.7M | $72.6M | ||
| Q1 25 | $241.0M | $61.0M | ||
| Q4 24 | $235.3M | $55.5M | ||
| Q3 24 | $233.5M | $57.7M | ||
| Q2 24 | $241.8M | $138.9M | ||
| Q1 24 | $236.9M | $79.3M |
股东权益CFBKFHTX
| Q4 25 | $184.4M | $-108.5M | ||
| Q3 25 | $179.3M | $-89.7M | ||
| Q2 25 | $177.0M | $-76.7M | ||
| Q1 25 | $172.7M | $-61.7M | ||
| Q4 24 | $168.4M | $-45.5M | ||
| Q3 24 | $164.0M | $-28.3M | ||
| Q2 24 | $159.6M | $-14.3M | ||
| Q1 24 | $158.0M | $-97.5M |
总资产CFBKFHTX
| Q4 25 | $2.1B | $198.1M | ||
| Q3 25 | $2.1B | $205.0M | ||
| Q2 25 | $2.1B | $226.2M | ||
| Q1 25 | $2.1B | $258.7M | ||
| Q4 24 | $2.1B | $284.0M | ||
| Q3 24 | $2.1B | $308.4M | ||
| Q2 24 | $2.0B | $328.6M | ||
| Q1 24 | $2.0B | $255.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.7M | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | $18.2M | — |
| 自由现金流率自由现金流/营收 | 115.6% | — |
| 资本支出强度资本支出/营收 | 3.1% | 0.0% |
| 现金转化率经营现金流/净利润 | 3.26× | — |
| 过去12个月自由现金流最近4个季度 | $33.4M | — |
8季度趋势，按日历期对齐
经营现金流CFBKFHTX
| Q4 25 | $18.7M | $-22.3M | ||
| Q3 25 | $5.5M | $-18.9M | ||
| Q2 25 | $8.0M | $-21.0M | ||
| Q1 25 | $2.2M | $-24.0M | ||
| Q4 24 | $14.2M | $-24.5M | ||
| Q3 24 | $-1.3M | $-21.0M | ||
| Q2 24 | $4.0M | $-25.5M | ||
| Q1 24 | $-1.2M | $-29.3M |
自由现金流CFBKFHTX
| Q4 25 | $18.2M | — | ||
| Q3 25 | $5.2M | — | ||
| Q2 25 | $7.8M | $-21.0M | ||
| Q1 25 | $2.2M | $-24.0M | ||
| Q4 24 | $13.9M | $-25.0M | ||
| Q3 24 | $-1.3M | $-21.3M | ||
| Q2 24 | $4.0M | $-25.6M | ||
| Q1 24 | $-1.2M | $-29.4M |
自由现金流率CFBKFHTX
| Q4 25 | 115.6% | — | ||
| Q3 25 | 33.6% | — | ||
| Q2 25 | 50.3% | -278.2% | ||
| Q1 25 | 15.2% | -403.2% | ||
| Q4 24 | 99.6% | -875.3% | ||
| Q3 24 | -9.9% | -273.0% | ||
| Q2 24 | 31.6% | -371.0% | ||
| Q1 24 | -9.5% | -583.1% |
资本支出强度CFBKFHTX
| Q4 25 | 3.1% | 0.0% | ||
| Q3 25 | 1.7% | 0.0% | ||
| Q2 25 | 0.7% | 0.3% | ||
| Q1 25 | 0.4% | 0.5% | ||
| Q4 24 | 1.9% | 16.8% | ||
| Q3 24 | 0.2% | 4.0% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.0% | 2.0% |
现金转化率CFBKFHTX
| Q4 25 | 3.26× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 1.58× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 3.21× | — | ||
| Q3 24 | -0.30× | — | ||
| Q2 24 | 2.35× | — | ||
| Q1 24 | -0.38× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
